MAPK1 and idiopathic pulmonary fibrosis: Through PPI network construction, we predicted that the core biological targets of YTG for IPF treatment were STAT3, SRC, MAPK3, MAPK1, RELA, PTPN11, JUN, MAPK14, STAT1, and EGFR.